Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
UroGen Pharma
URGN
$2.29B
| $1.03M | ﹤0.01% |
93,547
+30
| +0% | +$320 |
|
2827
Sierra Bancorp
BSRR
$533M
| $1.03M | ﹤0.01% |
37,067
| – | – |
|
2828
Telos
TLS
$341M
| $1.03M | ﹤0.01% |
433,133
-11,340
| -3% | -$34.8K |
|
2829
Lands' End
LE
$397M
| $1.03M | ﹤0.01% |
100,881
-2,520
| -2% | -$30K |
|
|
CRGX
2830
DELISTED
CARGO Therapeutics
CRGX
| $1.03M | ﹤0.01% |
252,004
-45,823
| -15% | -$307K |
|
2831
ACNB Corp
ACNB
$661M
| $1.02M | ﹤0.01% |
24,852
+9
| +0% | +$364 |
|
2832
ICL Group
ICL
$6.79B
| $1.02M | ﹤0.01% |
179,405
+34,333
| +24% | +$202K |
|
2833
Smith & Nephew
SNN
$12.4B
| $1.02M | ﹤0.01% |
35,890
+2,585
| +8% | +$69.1K |
|
|
LAND
2834
Gladstone Land Corp
LAND
$360M
| $1.02M | ﹤0.01% |
96,585
+240
| +0.2% | +$2.63K |
|
2835
Greenlight Captial
GLRE
$515M
| $1.02M | ﹤0.01% |
74,912
-2,293
| -3% | -$31.2K |
|
2836
Outdoor Holding Co
POWW
$253M
| $1.01M | ﹤0.01% |
734,569
+74,013
| +11% | +$115K |
|
2837
Cerence
CRNC
$410M
| $1.01M | ﹤0.01% |
127,974
-50,016
| -28% | -$615K |
|
|
ITIC
2838
Investors Title Co
ITIC
$540M
| $1.01M | ﹤0.01% |
4,169
| – | – |
|
2839
Ardmore Shipping
ASC
$695M
| $1M | ﹤0.01% |
102,510
-18,587
| -15% | -$203K |
|
2840
Prime Medicine
PRME
$553M
| $1M | ﹤0.01% |
503,697
+19,106
| +4% | +$48.7K |
|
|
TRML
2841
DELISTED
Tourmaline Bio
TRML
| $1M | ﹤0.01% |
65,850
+1,791
| +3% | +$28.7K |
|
2842
Talkspace
TALK
$874M
| $999K | ﹤0.01% |
390,154
+842
| +0.2% | +$2.62K |
|
|
NAGE
2843
Niagen Bioscience
NAGE
$239M
| $998K | ﹤0.01% |
144,623
+2
| +0% | +$13 |
|
2844
Design Therapeutics
DSGN
$868M
| $997K | ﹤0.01% |
258,375
-6,300
| -2% | -$30.1K |
|
|
PLL
2845
DELISTED
Piedmont Lithium
PLL
| $994K | ﹤0.01% |
157,742
+7,824
| +5% | +$62.5K |
|
|
PSTL
2846
Postal Realty Trust
PSTL
$697M
| $993K | ﹤0.01% |
69,521
+9,843
| +16% | +$132K |
|
|
EWCZ
2847
DELISTED
European Wax Center
EWCZ
| $992K | ﹤0.01% |
251,093
-1,589
| -0.6% | -$9.46K |
|
2848
Boston Omaha
BOC
$439M
| $988K | ﹤0.01% |
67,796
+11
| +0% | +$158 |
|
|
WBTN
2849
WEBTOON Entertainment Inc
WBTN
$1.2B
| $983K | ﹤0.01% |
128,114
-3,075
| -2% | -$33.6K |
|
2850
Stoneridge
SRI
$204M
| $981K | ﹤0.01% |
213,833
-53,024
| -20% | -$270K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.